Marker Therapeutics, Inc. Common Stock (MRKR) is a publicly traded Healthcare sector company. As of August 14, 2026, MRKR trades at $1.14 with a market cap of $19.34M and a P/E ratio of -1.44. MRKR moved +2.70% today. Year to date, MRKR is -25.97%; over the trailing twelve months it is -8.80%. Its 52-week range spans $0.81 to $4.07. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces MRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MRKR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.14 |
| Market Cap | $19.34M |
| P/E Ratio | -1.44 |
| EPS | $-0.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.07 |
| 52-Week Low | $0.81 |
| Volume | 44.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.55M |
| Net Income | $-12.16M |
| Gross Margin | 0.00% |
2 analysts cover MRKR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.00.